Cystic fibrosis pathophysiology: Difference between revisions

Jump to navigation Jump to search
Shamila Habibi (talk | contribs)
No edit summary
Shamila Habibi (talk | contribs)
Line 14: Line 14:


===Pathogenesis===
===Pathogenesis===
Cystic Fibrosis (CF) is an autosomal recessive, life-limiting disease resulting from mutations in the cystic fibrosis transmembrane conductance regulator (''CFTR'') gene. The gene is comprised of 27 exons and is situated on chromosome 7. The protein encoded by the ''CFTR'' gene is a cAMP-regulated chloride channel situated in the apical membrane of exocrine epithelial cells;1 other processes with which it is involved include regulation of the epithelial sodium channel, and bicarbonate transport. There is conflicting evidence on its role in regulating the pH of intracellular organelles and the consequences on cellular processes such as sialylation and sulfation. In patients with CF, CFTR protein function may be abnormal due to a lack of production (Class 1 mutations), failure to reach its site of action due to misfolding (Class 2; commonest Caucasian defect is Phe508Del), defects in gating (Class 3), conductance (Class 4), abnormally low channel numbers (Class 5), or decreased half-life (Class 6).
Whilst the CFTR protein is expressed in many internal organs, the major effect of such mutations is on the respiratory, gastrointestinal, and reproductive tracts, causing, in each of these sites, obstruction by thick, viscous secretions. Pulmonary disease leads to most of the morbidity associated with CF and is the cause of death in more than 90% of patients.2 The correlation of the molecular defect with this multi-system clinical picture is complex and not entirely understood. It has been shown that CF airway epithelia have abnormally high rates of sodium (and thus water) absorption, which dehydrates the airway surface liquid and impairs mucus transport. More recently, vibrating culture, which may recapitulate the in vivo setting better than the conventional static culture model, has demonstrated that these processes are well preserved until a “second hit” in the form of viral infection occurs.3 Once the airway surface becomes dehydrated, mucociliary clearance (MCC) mechanisms fail to remove any inhaled bacteria, which infect the lower airways and lead to inflammation. The CF inflammatory response is abnormal in several ways, being exaggerated,4 prolonged5 and, at least in chronic stages of infection, ineffectual.6 The presence of inflammatory cell contents such as DNA and elastase in the airway further increase mucus viscosity and contribute to tissue breakdown.


==Genetics==
==Genetics==
[[Image:CFTR.jpg|thumb|left|350px|'''CFTR protein -''' Molecular structure of the CFTR protein]]
[[Image:CFTR.jpg|thumb|left|350px|'''CFTR protein -''' Molecular structure of the CFTR protein]]
The [[CFTR (gene)|CFTR gene]] is found at the q31.2 [[locus (genetics)|locus]] of [[chromosome 7]], is 230 000 [[base pair]]s long, and creates a protein that is 1,480 [[amino acid]]s long. The most common mutation, [[ΔF508]] is a deletion (Δ) of three nucleotides that results in a loss of the amino acid [[phenylalanine]] (F) at the 508th (508) position on the protein. This mutation accounts for seventy percent of CF worldwide and 90 percent of cases in the United States. There are over 1,400 other mutations that can produce CF, however. In Caucasian populations, the frequency of mutations is as follows:<ref name="table">''Prevalence of ΔF508, G551D, G542X, R553X mutations among cystic fibrosis patients in the North of Brazil.'' Brazilian Journal of Medical and Biological Research 2005; 38:11–15. PMID 15665983</ref>{{entête tableau charte alignement|left}}<noinclude></noinclude>
The cystic fibrosis transmembrane conductance regulator ([[CFTR (gene)|CFTR) gene]] is found at the q31.2 [[locus (genetics)|locus]] of [[chromosome 7]]. It is 230 000 [[base pair]]s long, comprised of 27 exons and creates a protein that is 1,480 [[amino acid]]s long. The most common mutation, [[ΔF508]] is a deletion (Δ) of three nucleotides that results in a loss of the amino acid [[phenylalanine]] (F) at the 508th (508) position on the protein.
 
This mutation accounts for 70% of cystic fibrosis worldwide and 90% of cases in the United States. There are over 1,400 other mutations that can produce cystic fibrosis, however. In Caucasian populations, the frequency of mutations is as follows:<ref name="table">''Prevalence of ΔF508, G551D, G542X, R553X mutations among cystic fibrosis patients in the North of Brazil.'' Brazilian Journal of Medical and Biological Research 2005; 38:11–15. PMID 15665983</ref>{{entête tableau charte alignement|left}}<noinclude></noinclude>
! Mutation
! Mutation
! Frequency<br/>worldwide
! Frequency<br/>worldwide

Revision as of 14:50, 8 February 2018

https://https://www.youtube.com/watch?v=BhFpFiZumS0%7C350}}

Cystic fibrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cystic fibrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cystic fibrosis pathophysiology On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cystic fibrosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cystic fibrosis pathophysiology

CDC on Cystic fibrosis pathophysiology

Cystic fibrosis pathophysiology in the news

Blogs on Cystic fibrosis pathophysiology

Directions to Hospitals Treating Cystic fibrosis

Risk calculators and risk factors for Cystic fibrosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]

Overview

Pathophysiology

Pathogenesis

Cystic Fibrosis (CF) is an autosomal recessive, life-limiting disease resulting from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The gene is comprised of 27 exons and is situated on chromosome 7. The protein encoded by the CFTR gene is a cAMP-regulated chloride channel situated in the apical membrane of exocrine epithelial cells;1 other processes with which it is involved include regulation of the epithelial sodium channel, and bicarbonate transport. There is conflicting evidence on its role in regulating the pH of intracellular organelles and the consequences on cellular processes such as sialylation and sulfation. In patients with CF, CFTR protein function may be abnormal due to a lack of production (Class 1 mutations), failure to reach its site of action due to misfolding (Class 2; commonest Caucasian defect is Phe508Del), defects in gating (Class 3), conductance (Class 4), abnormally low channel numbers (Class 5), or decreased half-life (Class 6).

Whilst the CFTR protein is expressed in many internal organs, the major effect of such mutations is on the respiratory, gastrointestinal, and reproductive tracts, causing, in each of these sites, obstruction by thick, viscous secretions. Pulmonary disease leads to most of the morbidity associated with CF and is the cause of death in more than 90% of patients.2 The correlation of the molecular defect with this multi-system clinical picture is complex and not entirely understood. It has been shown that CF airway epithelia have abnormally high rates of sodium (and thus water) absorption, which dehydrates the airway surface liquid and impairs mucus transport. More recently, vibrating culture, which may recapitulate the in vivo setting better than the conventional static culture model, has demonstrated that these processes are well preserved until a “second hit” in the form of viral infection occurs.3 Once the airway surface becomes dehydrated, mucociliary clearance (MCC) mechanisms fail to remove any inhaled bacteria, which infect the lower airways and lead to inflammation. The CF inflammatory response is abnormal in several ways, being exaggerated,4 prolonged5 and, at least in chronic stages of infection, ineffectual.6 The presence of inflammatory cell contents such as DNA and elastase in the airway further increase mucus viscosity and contribute to tissue breakdown.

Genetics

CFTR protein - Molecular structure of the CFTR protein

The cystic fibrosis transmembrane conductance regulator (CFTR) gene is found at the q31.2 locus of chromosome 7. It is 230 000 base pairs long, comprised of 27 exons and creates a protein that is 1,480 amino acids long. The most common mutation, ΔF508 is a deletion (Δ) of three nucleotides that results in a loss of the amino acid phenylalanine (F) at the 508th (508) position on the protein.

This mutation accounts for 70% of cystic fibrosis worldwide and 90% of cases in the United States. There are over 1,400 other mutations that can produce cystic fibrosis, however. In Caucasian populations, the frequency of mutations is as follows:[1]Template:Entête tableau charte alignement ! Mutation ! Frequency
worldwide |----- | ΔF508 | 66.0% |-Template:Ligne grise | G542X | 2.4% |----- | G551D | 1.6% |-Template:Ligne grise | N1303K | 1.3% |----- | W1282X | 1.2% |}
There are several mechanisms by which these mutations cause problems with the CFTR protein. ΔF508, for instance, creates a protein that does not fold normally and is degraded by the cell. Several mutations, which are common in the Ashkenazi Jewish population, result in proteins that are too short because production is ended prematurely. Less common mutations produce proteins that do not use energy normally, do not allow chloride to cross the membrane appropriately, or are degraded at a faster rate than normal. Mutations may also lead to fewer copies of the CFTR protein being produced.

The location of the CFTR gene on chromosome 7

Structurally, CFTR is a type of gene known as an ABC gene. Its protein possesses two ATP-hydrolyzing domains which allows the protein to use energy in the form of ATP. It also contains two domains comprised of 6 alpha helices apiece, which allow the protein to cross the cell membrane. A regulatory binding site on the protein allows activation by phosphorylation, mainly by cAMP-dependent protein kinase. The carboxyl terminal of the protein is anchored to the cytoskeleton by a PDZ domain interaction.[2]

Images courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology


Associated Conditions

Gross Pathology

Microscopic Pathology

  • On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

References

  1. Prevalence of ΔF508, G551D, G542X, R553X mutations among cystic fibrosis patients in the North of Brazil. Brazilian Journal of Medical and Biological Research 2005; 38:11–15. PMID 15665983
  2. Short DB, Trotter KW, Reczek D, Kreda SM, Bretscher A, Boucher RC, Stutts MJ, Milgram SL. An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J Biol Chem. 1998 Jul 31;273(31):19797-801. PMID 9677412

Template:WH Template:WS